Innovative Medicines Fund and the opportunity for ICSs to mobilise NICE approvals
Wednesday 23rd November – 12:30pm – 1:30pm GMT
Click here to book your tickets: Innovative Medicines Fund and the opportunity for ICSs to mobilise NICE approvals – (pharmaphorum.com)
Earlier this year, NHSE and NICE published details on the Innovative Medicines Fund, which will help improve patient access to cutting-edge medicines, with a particular focus on rare diseases, and ensure global pharmaceutical and biotech organizations continue to prioritize the UK as a launch.
To discuss the implications for industry organizations in securing funding via this route PharmaPhorum and IQVIA are convening key experts and stakeholders at a special online webinar.
Speakers:
Angela McFarlane?, VP Strategic Planning, IQVIA UK & Ireland and North Europe
Nina Pinwill BSc (Hons) MSc DIC, is the Head of Commercial Operations at NHS England and NHS Improvement
Sean Richardson, VP & General Manager UK & Ireland, Alexion
Thomas Strong, Interim Associate Director – Managed Access, NICE
Mohammed Asghar, Frimley Health and Care ICS Prescribing Governance Lead
Jay Hamilton, programme director – Industry Partnerships, Health Innovation Manchester
